Organization
Michael Peluso, MD
1 clinical trial
Clinical trial
An Exploratory, Randomized, Double-Blind Placebo-Controlled Study to Assess the Safety of an Anti-SARS-CoV-2 Monoclonal Antibody and Response to Treatment in Individuals With Long COVID (outSMART-LC)Status: Active (not recruiting), Estimated PCD: 2025-07-31